Phosphoproteins Identification on Stretchable Photonic Crystal for Cervical Cancer Assessment

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• Cervical cancer poses a significant threat to women's health, necessitating early detection.
• Current diagnostic methods are often invasive, costly, and complex, hindering widespread clinical application.
• A need exists for rapid, low-cost, minimally invasive, and highly sensitive cervical cancer assessment tools.

Purpose of the Study:

• To develop a novel phosphoprotein identification method for cervical cancer assessment.
• To create a rapid, low-cost, and minimally invasive diagnostic approach.
• To accurately stage cervical cancer using serum samples.

Main Methods:

• A stretchable photonic crystal was engineered to host three fluorescent probes, forming a cross-response sensor.
• The photonic bandgap was dynamically tuned via mechanical stretching to optimize fluorescence.
• Serum samples were analyzed to detect specific phosphoprotein level changes indicative of cervical cancer stages.

Main Results:

• The developed sensor achieved an accuracy rate of up to 94% in pinpointing cervical cancer stages.
• The method demonstrated signal amplification through enhanced fluorescence and amplified signal differences.
• No additional probe synthesis or labeling was required, simplifying the process.

Conclusions:

• This phosphoprotein identification method based on stretchable photonic crystals provides a simple and efficient approach for cervical cancer assessment.
• The technique shows significant clinical promise for early and accurate detection of cervical cancer.
• The study highlights the potential of photonic crystals in developing advanced diagnostic tools for women's health.